Report Detail
Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2019-2025
- RnM3674282 |
- 16 August, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Pharma & Healthcare
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.
The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs market growth during the forecast period. With the increase in the prevalence of lung cancer, the need for a strong pipeline of disease-modifying drugs is also increasing.
In 2018, the global Non-small Cell Lung Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-small Cell Lung Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-small Cell Lung Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
...
Market segment by Type, the product can be split into
Biologics
Small Molecule Targeted Therapy
Chemotherapy
Other
Market segment by Application, split into
Lung Adenocarcinoma
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-small Cell Lung Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Non-small Cell Lung Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-small Cell Lung Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Biologics
- 1.4.3 Small Molecule Targeted Therapy
- 1.4.4 Chemotherapy
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2025)
- 1.5.2 Lung Adenocarcinoma
- 1.5.3 Squamous Cell Lung Carcinoma
- 1.5.4 Large-cell Lung Carcinoma
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Non-small Cell Lung Cancer Drugs Market Size
- 2.2 Non-small Cell Lung Cancer Drugs Growth Trends by Regions
- 2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Regions (2019-2025)
- 2.2.2 Non-small Cell Lung Cancer Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Non-small Cell Lung Cancer Drugs Market Size by by Players
- 3.1.1 Global Non-small Cell Lung Cancer Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Non-small Cell Lung Cancer Drugs Key Players Head office and Area Served
- 3.3 Key Players Non-small Cell Lung Cancer Drugs Product/Solution/Service
- 3.4 Date of Enter into Non-small Cell Lung Cancer Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Non-small Cell Lung Cancer Drugs Market Size by Type (2014-2019)
- 4.2 Global Non-small Cell Lung Cancer Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 5.2 Non-small Cell Lung Cancer Drugs Key Players in North America
- 5.3 North America Non-small Cell Lung Cancer Drugs Market Size by Type
- 5.4 North America Non-small Cell Lung Cancer Drugs Market Size by Application
6 Europe
- 6.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 6.2 Non-small Cell Lung Cancer Drugs Key Players in Europe
- 6.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Type
- 6.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Application
7 China
- 7.1 China Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 7.2 Non-small Cell Lung Cancer Drugs Key Players in China
- 7.3 China Non-small Cell Lung Cancer Drugs Market Size by Type
- 7.4 China Non-small Cell Lung Cancer Drugs Market Size by Application
8 Japan
- 8.1 Japan Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 8.2 Non-small Cell Lung Cancer Drugs Key Players in Japan
- 8.3 Japan Non-small Cell Lung Cancer Drugs Market Size by Type
- 8.4 Japan Non-small Cell Lung Cancer Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 9.2 Non-small Cell Lung Cancer Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Type
- 9.4 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Application
10 India
- 10.1 India Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 10.2 Non-small Cell Lung Cancer Drugs Key Players in India
- 10.3 India Non-small Cell Lung Cancer Drugs Market Size by Type
- 10.4 India Non-small Cell Lung Cancer Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
- 11.2 Non-small Cell Lung Cancer Drugs Key Players in Central & South America
- 11.3 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Type
- 11.4 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Application
12 International Players Profiles
- 12.1 AstraZeneca
- 12.1.1 AstraZeneca Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Non-small Cell Lung Cancer Drugs Introduction
- 12.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019))
- 12.1.5 AstraZeneca Recent Development
- 12.2 Bristol-Myers Squibb Company
- 12.2.1 Bristol-Myers Squibb Company Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Non-small Cell Lung Cancer Drugs Introduction
- 12.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
- 12.2.5 Bristol-Myers Squibb Company Recent Development
- 12.3 Eli Lilly and Company
- 12.3.1 Eli Lilly and Company Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Non-small Cell Lung Cancer Drugs Introduction
- 12.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
- 12.3.5 Eli Lilly and Company Recent Development
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4.1 F. Hoffmann-La Roche Ltd Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Non-small Cell Lung Cancer Drugs Introduction
- 12.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
- 12.4.5 F. Hoffmann-La Roche Ltd Recent Development
- 12.5 Merck & Co., Inc.
- 12.5.1 Merck & Co., Inc. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Non-small Cell Lung Cancer Drugs Introduction
- 12.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
- 12.5.5 Merck & Co., Inc. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Non-small Cell Lung Cancer Drugs. Industry analysis & Market Report on Non-small Cell Lung Cancer Drugs is a syndicated market report, published as Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Non-small Cell Lung Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
